Evidence map›Paper›PMID 39951296›Full record

ArticleInvestigative ophthalmology & visual science2025

Chiasmal Decussation in Oculo-Cutaneous Albinism Type 8.

Maxence Rateaux, Smaïl Hadj-Rabia, Rémi Barrois, Olivia Zambrowski, Vincent Michaud, Ester Moreno-Artero, Dominique Bremond-Gignac, Sophie Javerzat, Matthieu P Robert

Abstract readCase Reports
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maxence RateauxOphthalmology Department and Reference Centre for Rare Ophthalmology Diseases, (OPHTARA), ERN-Eye, University Hospital Necker-Enfants Malades, APHP, Paris, France.
Smaïl Hadj-RabiaDermatology Department and Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), FIMARAD, ERN-Skin, Paris Cité University, INSERM U1163, Institut Imagine, University Hospital Necker-Enfants Malades, APHP, Paris, France.
Rémi BarroisCentre Borelli, Paris Cité University, ENS Paris-Saclay, CNRS, INSERM, SSA, Paris, France.
Olivia ZambrowskiOphthalmology Department and Reference Centre for Rare Ophthalmology Diseases, (OPHTARA), ERN-Eye, University Hospital Necker-Enfants Malades, APHP, Paris, France.
Vincent MichaudMedical Genetic Department, University Hospital of Bordeaux, Bordeaux, France.
Ester Moreno-ArteroDermatology Department and Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), FIMARAD, ERN-Skin, Paris Cité University, INSERM U1163, Institut Imagine, University Hospital Necker-Enfants Malades, APHP, Paris, France.
Dominique Bremond-GignacINSERM UMRS 1138, T17, Centre des Cordeliers, Paris Cité University, Paris, France.
Sophie JaverzatRare Diseases Genetics and Metabolism, INSERM U1211, SBM Department, University of Bordeaux, Bordeaux, France.
Matthieu P RobertOphthalmology Department and Reference Centre for Rare Ophthalmology Diseases, (OPHTARA), ERN-Eye, University Hospital Necker-Enfants Malades, APHP, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Albinism is a genetic disorder characterized by a defect in melanin biosynthesis. Ophthalmological and dermatological impairments vary according to the patient genotype and are highly heterogenous. Recently, variants in the DCT gene were showed to be responsible for a new type of oculocutaneous albinism (OCA) named OCA8. We report the ophthalmological, electrophysiological, and dermatological characteristics of three patients with genetically confirmed OCA8. Methods: This is a retrospective study of three patients with OCA8. Complete dermatological, ophthalmological, and orthoptic examinations were performed with clinical exploration and multimodal imaging. Visual evoked potentials (VEPs) were performed to characterize chiasmal decussation in two of the three patients. Results: The dermatological phenotype was mild, whereas all three patients exhibited infantile nystagmus syndrome with reduced visual acuity, foveal hypoplasia (grade 3), macular hypopigmentation (graded from 2 to 1), and iris transillumination (grade 3). Patients who could undergo a VEP examination exhibited signs of strong chiasmal misrouting. Conclusions: Recently, pathogenic variants in the DCT gene were proven to cause OCA. Whereas patients with OCA8 exhibit a milder dermatological phenotype than others, their vision was initially described as impaired. The present report confirms previous findings and suggests that chiasmal misrouting is present in OCA8. This, together with recent findings in the murine model, supports the hypothesis that DCT regulates levels of L-Dopa and downstream signaling in the developing retina. These results convey critical future therapeutic implications.

Indexed as

Albinism, OculocutaneousEvoked Potentials, VisualFemaleHumansPhenotypeRetrospective StudiesTomography, Optical CoherenceVisual Acuity

Identifiers

PMID39951296
PMCPMC11824501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.